Over the past few years we've been tracking the updates and clarifications to the physician supervision requirements for therapeutic services delivered in the hospital outpatient department. We've got a new round of updates for you courtesy of the recently released final payment rule from CMS. With these latest statements, CMS continues to take a more stringent view of supervision.
CMS Issues Clarifications to Physician Supervision Rules
Radiation dose continues to be top of mind for imaging leaders, especially since the reported high patient exposures at a California hospital that occurred during CT brain perfusion studies in September of 2009. This week, the FDA offered five suggestions
on how to limit dose and prevent unintentional exposure. After a thorough investigation, the FDA found that In the 206 cases of radiation over-exposure that occurred last year, a computer-resetting error appeared to be the cause of the problem. The FDA thus submitted their suggestions to the Medical Imaging and Technology Alliance (MITA) for consideration.
FDA Submits Radiation Exposure Recommendations to CT Vendors
I'm a little late in responding to this article, but wanted to take the time to give my thoughts since many members have forwarded it to me asking for comment. The article, provocatively titled "Hospital C-Suite Reality Check," makes a number of statements that I agree with: that successful outpatient imaging enterprises will spring from collaborative relationships (but not necessarily economic partnership) between hospitals and radiologists; that the focus on health care costs in the reform debates is putting imaging charges under an uncomfortable lens; that the Hospital Outpatient Prospective Payment System now has the payment advantage.
Hospital Medicare Imaging Payment: What Will the Future Hold?